These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35412213)

  • 1. Incidence of SARS-CoV-2 re-infection in anti-nucleocapsid IgG-positive healthcare workers: a prospective cohort study.
    Mehboob S; Rehman A; Haq M; Rajab H; Haq M; Haq H; Ahmad J; Ahmad S; Abbas M; Anwar S; Haq N
    Ir J Med Sci; 2023 Apr; 192(2):915-918. PubMed ID: 35412213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
    Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
    PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monitoring of anti-SARS-CoV-2 IgG antibody immune responses in two cohorts of Hungarian healthcare workers following infection or immunization].
    Gervain J; Szabóné Bartha K; Bakiné Hodovánszky E; Kadlecsik L; Herczeg R; Gyenesei A; Simon J
    Orv Hetil; 2022 Mar; 163(12):455-462. PubMed ID: 35306478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers.
    Lumley SF; Wei J; O'Donnell D; Stoesser NE; Matthews PC; Howarth A; Hatch SB; Marsden BD; Cox S; James T; Peck LJ; Ritter TG; de Toledo Z; Cornall RJ; Jones EY; Stuart DI; Screaton G; Ebner D; Hoosdally S; Crook DW; Conlon CP; Pouwels KB; Walker AS; Peto TEA; Walker TM; Jeffery K; Eyre DW;
    Clin Infect Dis; 2021 Aug; 73(3):e699-e709. PubMed ID: 33400782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of anti-SARS-CoV-2 immune response in a cohort of French healthcare workers followed for 7 months.
    Pilmis B; Elkaibi I; Péan de Ponfilly G; Daikha H; Bouzid A; Guihot A; Castreau N; Pradere P; Ketatni H; Mondragon A; Hayem G; Le Pavec J; Laplanche S; Le Monnier A
    Infect Dis Now; 2022 Mar; 52(2):68-74. PubMed ID: 35063702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
    Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S
    EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.
    Lumley SF; O'Donnell D; Stoesser NE; Matthews PC; Howarth A; Hatch SB; Marsden BD; Cox S; James T; Warren F; Peck LJ; Ritter TG; de Toledo Z; Warren L; Axten D; Cornall RJ; Jones EY; Stuart DI; Screaton G; Ebner D; Hoosdally S; Chand M; Crook DW; O'Donnell AM; Conlon CP; Pouwels KB; Walker AS; Peto TEA; Hopkins S; Walker TM; Jeffery K; Eyre DW;
    N Engl J Med; 2021 Feb; 384(6):533-540. PubMed ID: 33369366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
    Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
    JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-nucleocapsid IgG antibodies in SARS-CoV-2 recovered health care workers: One year follow-up study.
    Ahmad A; Haq M; Rehman A; Haq NU
    Int J Immunopathol Pharmacol; 2023; 37():3946320231187744. PubMed ID: 37394899
    [No Abstract]   [Full Text] [Related]  

  • 10. Epitope Coverage of Anti-SARS-CoV-2 Nucleocapsid IgA and IgG Antibodies Correlates with Protection against Re-Infection by New Variants in Subsequent Waves of the COVID-19 Pandemic.
    Mullins MO; Smith M; Maboreke H; Nel AJM; Ntusi NAB; Burgers WA; Blackburn JM
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort study.
    Atzl M; Muendlein A; Winder T; Fraunberger P; Brandtner EM; Geiger K; Klausberger M; Duerkop M; Sprenger L; Mutschlechner B; Volgger A; Benda M; Severgnini L; Jaeger JB; Drexel H; Lang A; Leiherer A
    BMJ Open; 2022 May; 12(5):e052130. PubMed ID: 35613821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
    Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
    PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine].
    Keskin AÜ; Dalan AB; Çıragil P; Topkaya AE
    Mikrobiyol Bul; 2022 Jul; 56(3):480-492. PubMed ID: 35960239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic Status and SARS-CoV-2 Infection over 6 Months of Follow Up in Healthcare Workers in Chicago: A Cohort Study.
    Wilkins JT; Hirschhorn LR; Gray EL; Wallia A; Carnethon M; Zembower TR; Ho J; DeYoung BJ; Zhu A; Rasmussen-Torvik LJ; Taiwo B; Evans CT
    Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1207-1215. PubMed ID: 34369331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS COV-2 anti-nucleocapsid and anti-spike antibodies in an emergency department healthcare worker cohort: September 2020 - April 2021.
    Wang RC; Murphy CE; Kornblith AE; Hohenstein NA; Carter CM; Wong AHK; Kurtz T; Kohn MA
    Am J Emerg Med; 2022 Apr; 54():81-86. PubMed ID: 35144108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
    Hall VJ; Foulkes S; Charlett A; Atti A; Monk EJM; Simmons R; Wellington E; Cole MJ; Saei A; Oguti B; Munro K; Wallace S; Kirwan PD; Shrotri M; Vusirikala A; Rokadiya S; Kall M; Zambon M; Ramsay M; Brooks T; Brown CS; Chand MA; Hopkins S;
    Lancet; 2021 Apr; 397(10283):1459-1469. PubMed ID: 33844963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence, correlates and kinetics of SARS-CoV-2 nucleocapsid IgG antibody in healthcare workers and nonclinical staff at a tertiary hospital: A prevaccine census study.
    Maina D; Omuse G; Ong'ete G; Mugaine P; Sayed S; Moloo Z; Shah R; Etyang A; Adam R
    PLoS One; 2022; 17(10):e0267619. PubMed ID: 36301926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland.
    Faller E; Wyse A; Barry R; Conlon K; Everard C; Finnegan P; Foran C; Herlihy E; Kerr G; Lapthorne S; McGreal-Bellone A; Morrissey E; O'Sullivan D; O'Sullivan G; Eustace JA; Spillane D; Dempsey C; Benson J; Prentice M; Gallagher J; MacSharry J; Fanning LJ; O'Riordan S; Horgan M; Sadlier C
    BMJ Open; 2021 Jun; 11(6):e051415. PubMed ID: 34103324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
    Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
    J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term evolution of humoral immune response after SARS-CoV-2 infection.
    Teyssou E; Zafilaza K; Sayon S; Marot S; Dropy M; Soulie C; Abdi B; Tubach F; Hausfater P; Marcelin AG; Boutolleau D;
    Clin Microbiol Infect; 2022 Jul; 28(7):1027.e1-1027.e4. PubMed ID: 35307573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.